AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 48 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,072,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $38,130,000 | 36.42% |
| FRAZIER MANAGEMENT LLC | 3,746,857 | $19,446,000 | 1.50% |
| TFG Asset Management GP Ltd | 2,700,000 | $14,013,000 | 0.84% |
| Nantahala Capital Management | 4,077,509 | $21,162,000 | 0.74% |
| Ikarian Capital, LLC | 544,819 | $2,827,000 | 0.42% |
| HARBOR CAPITAL ADVISORS, INC. | 211,319 | $1,097,000 | 0.40% |
| Blackstone Inc. | 17,985,611 | $93,345,000 | 0.23% |
| Resolute Capital Asset Partners LLC | 65,115 | $338,000 | 0.22% |
| MYDA Advisors LLC | 125,000 | $649,000 | 0.17% |
| Eversept Partners, LP | 401,540 | $2,083,993 | 0.13% |